{
  "schema": "http://google-preview.miscsubjects.com/schemas/jarticle.json",
  "status": "published",
  "slug": "semaglutide-glp1-agonists",
  "title": "semaglutide glp1 agonists",
  "kind": "standard",
  "summary": "Evidence is being populated by Grok web",
  "created": "2026-06-29T17:47:38.507Z",
  "body": [
    "## Overview\nEvidence is being populated by Grok web search."
  ],
  "facts": {
    "converted_from": "markdown",
    "original_updated": "2026-06-29T17:47:40.716Z",
    "register": "standard",
    "category": null
  },
  "sources": [
    {
      "id": "s1",
      "type": "pubmed",
      "url": "https://pubmed.ncbi.nlm.nih.gov/40829097/",
      "title": "Trends in glucagon-like peptide 1 receptor agonist prescribing patterns",
      "quote": "From 2018 to 2023, GLP-1 RA prescribing increased significantly, with semaglutide approved for weight loss rising to 60% share in the nondiabetic obese/overweight group.",
      "summary": "Analysis of GLP-1 RA prescribing from 2018-2023 shows sharp rise, especially semaglutide for weight loss reaching 60% share in non-diabetic obese/overweight patients.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [],
      "found_by": "grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T17:47:38.639Z",
      "link_status": "ok",
      "quote_status": "verified",
      "prev": "genesis",
      "hash": "7acee6853c646b10997a58ea4f1cf8c08dd2b8ca96a81a53675c65455eeb1b48",
      "quote_sha256": "0fd029c6a70cfe030ffc41450877010c944fc51a77fc7a27b2687440a9d81cba"
    },
    {
      "id": "s2",
      "type": "pubmed",
      "url": "https://pubmed.ncbi.nlm.nih.gov/41824845/",
      "title": "GLP-1 receptor agonists for weight loss: A systematic review and meta-analysis of randomized controlled trials",
      "quote": "GLP-1 receptor agonists significantly increase the likelihood of weight loss versus placebo, with tirzepatide and semaglutide demonstrating the greatest relative efficacy among agents evaluated.",
      "summary": "2026 meta-analysis of 16 RCTs confirms GLP-1 RAs (esp. tirzepatide and semaglutide) superior for weight loss vs placebo.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [],
      "found_by": "grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T17:47:38.639Z",
      "link_status": "ok",
      "quote_status": "verified",
      "prev": "7acee6853c646b10997a58ea4f1cf8c08dd2b8ca96a81a53675c65455eeb1b48",
      "hash": "7a8ee73d77006c520a32629570c193ca96a8dab23fb227ac490c44530b8f1df2",
      "quote_sha256": "e1ded765184f66c5bdb43cea297f5d0a618f6535061e32d116bdf244c5057519"
    },
    {
      "id": "s3",
      "type": "pubmed",
      "url": "https://pubmed.ncbi.nlm.nih.gov/40536520/",
      "title": "Semaglutide versus other GLP-1 receptor agonists in patients with MASLD",
      "quote": "Compared to other GLP-1RAs, semaglutide was associated with a 14% lower risk of primary composite outcomes... reduced risks of all-cause mortality (aHR, 0.68) and major adverse liver outcomes (aHR, 0.79).",
      "summary": "2025 study finds semaglutide superior to other GLP-1RAs in MASLD patients for reducing mortality and liver outcomes.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [],
      "found_by": "grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T17:47:38.639Z",
      "link_status": "ok",
      "quote_status": "unverified",
      "prev": "7a8ee73d77006c520a32629570c193ca96a8dab23fb227ac490c44530b8f1df2",
      "hash": "f65b4ec7f9390db2b9e58da32b4113d170a51fe4615cf7d6a8eb0ae4b77314f0",
      "quote_sha256": "e13ccc054838bd330984ab82b886a61358e39156836729a4ada18fb1084c710e"
    },
    {
      "id": "s4",
      "type": "clinical_trial",
      "url": "https://clinicaltrials.gov/study/NCT05564117",
      "title": "Research Study Looking at How Well Semaglutide Tablets Taken Once Daily Work in People Who Have a Body Weight Above the Healthy Range (OASIS 4)",
      "quote": "Participants will either get semaglutide 25 milligram (mg) once daily or placebo once daily. This study will last for 72 weeks...",
      "summary": "Ongoing/completed OASIS 4 trial evaluating daily oral semaglutide 25mg for weight management in overweight/obese adults.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [],
      "found_by": "grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T17:47:38.639Z",
      "link_status": "ok",
      "quote_status": "unverified",
      "prev": "f65b4ec7f9390db2b9e58da32b4113d170a51fe4615cf7d6a8eb0ae4b77314f0",
      "hash": "be117bf019ae2c28fe14883ac9dafa1865dda91540914d6c4648a178a827cec7",
      "quote_sha256": "df3ae37c0a3252105ef1ad5b21fcd303e126e93daaa9ca4138b4877bd073e126"
    },
    {
      "id": "s5",
      "type": "review",
      "url": "https://www.nature.com/articles/s41591-025-03978-z",
      "title": "A systematic review and meta-analysis of the efficacy and safety of GLP-1 receptor agonists",
      "quote": "Semaglutide was effective in reducing major adverse cardiovascular events and reducing pain in knee osteoarthritis. Tirzepatide was effective in...",
      "summary": "2025 Nature Medicine review/meta-analysis on efficacy/safety of GLP-1 RAs including semaglutide benefits for CV events and osteoarthritis.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [],
      "found_by": "grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T17:47:38.639Z",
      "link_status": "ok",
      "quote_status": "unverified",
      "prev": "be117bf019ae2c28fe14883ac9dafa1865dda91540914d6c4648a178a827cec7",
      "hash": "91a9f0135ddc0ef1e9149006e23aac6f13404b894edd5302dcdcb41a4ef5fa00",
      "quote_sha256": "da4300d821b85c11d0a71ac5344f7b8c52aa90819b854552773fb34cb5f5f379"
    }
  ],
  "type": "article",
  "updated": "2026-10-08T11:49:29.748Z",
  "version": 1,
  "hash": "4b97a2982dcbb6cd96f2dcc983306c7e074e2b01969550b0b48e6f86d0d0a299",
  "styling": {
    "scope": "shared",
    "how": "no value on the page is set by hand: each comes from this theme, and each theme value becomes the CSS variable named beside it. PATCH http://google-preview.miscsubjects.com/api/jarticles/theme changes them.",
    "widget_style": {
      "what": "every widget may carry style: {…}; these are the only keys it reads",
      "rotate": "degrees, a number",
      "offset_x": "pixels, a number",
      "offset_y": "pixels, a number",
      "pulse": "true to pulse"
    },
    "theme": {
      "color": {
        "page_bg": "#f5f5f7",
        "sheet_bg": "#ffffff",
        "ink": "#1d1d1f",
        "soft": "#424245",
        "muted": "#6e6e73",
        "dim": "#86868b",
        "line": "#d2d2d7",
        "accent": "#0071e3",
        "accent_soft": "rgba(0,113,227,0.08)",
        "link": "#0066cc",
        "selection": "rgba(0,113,227,0.18)",
        "widget_bg": "#f5f5f7",
        "widget_border": "#d2d2d7",
        "card_bg": "#ffffff",
        "code_bg": "#f5f5f7",
        "json_bg": "#161b19",
        "json_ink": "#e6e1d4",
        "json_key": "#7fd3c3",
        "json_string": "#e9c46a",
        "json_number": "#f4a261",
        "json_bool": "#c792ea",
        "json_null": "#928d7e",
        "json_punct": "#6b6759",
        "json_bar": "#0e1512",
        "kind_badge_bg": "#0e6e60",
        "kind_badge_ink": "#ffffff"
      },
      "color_dark": {
        "page_bg": "#000000",
        "sheet_bg": "#1d1d1f",
        "ink": "#f5f5f7",
        "soft": "#d2d2d7",
        "muted": "#a1a1a6",
        "dim": "#86868b",
        "line": "#424245",
        "accent": "#2997ff",
        "accent_soft": "rgba(41,151,255,0.12)",
        "link": "#2997ff",
        "selection": "rgba(41,151,255,0.25)",
        "widget_bg": "#2c2c2e",
        "widget_border": "#424245",
        "card_bg": "#1d1d1f",
        "code_bg": "#2c2c2e",
        "json_bg": "#0a0d0c",
        "json_ink": "#e6e1d4",
        "json_key": "#7fd3c3",
        "json_string": "#e9c46a",
        "json_number": "#f4a261",
        "json_bool": "#c792ea",
        "json_null": "#757062",
        "json_punct": "#5d665f",
        "json_bar": "#060807",
        "kind_badge_bg": "#4fc1ab",
        "kind_badge_ink": "#0b0f0d"
      },
      "font": {
        "display": "-apple-system,BlinkMacSystemFont,\"SF Pro Display\",\"SF Pro Text\",\"Helvetica Neue\",Helvetica,Arial,sans-serif",
        "body": "-apple-system,BlinkMacSystemFont,\"SF Pro Display\",\"SF Pro Text\",\"Helvetica Neue\",Helvetica,Arial,sans-serif",
        "mono": "ui-monospace,SFMono-Regular,\"SF Mono\",Menlo,Consolas,monospace",
        "google_fonts": ""
      },
      "size": {
        "body": "17px",
        "small": "17px",
        "eye": "17px",
        "lead": "17px",
        "h1": "52px",
        "h2": "34px",
        "h3": "22px",
        "byline": "17px",
        "h1_measure": "none",
        "code": "17px",
        "json": "17px",
        "widget_title": "17px"
      },
      "leading": {
        "body": "1.7",
        "head": "1.18",
        "lead": "1.5",
        "json": "1.6"
      },
      "weight": {
        "display": "700",
        "head": "700",
        "body": "400",
        "strong": "700",
        "eye": "700"
      },
      "tracking": {
        "eye": "0.14em",
        "display": "-0.03em",
        "body": "-0.006em",
        "badge": "0.08em"
      },
      "layout": {
        "sheet_width": "1000px",
        "text_width": "880px",
        "gutter": "16px",
        "sheet_padding": "56px 64px 64px",
        "sheet_padding_mobile": "24px 18px 40px",
        "sheet_margin": "28px auto 72px",
        "block_gap": "1.15em",
        "widget_gap": "28px",
        "grid_gap": "14px"
      },
      "border": {
        "sheet": "0px solid",
        "sheet_radius": "30px",
        "widget": "1px solid",
        "widget_radius": "24px",
        "card_radius": "24px",
        "badge_radius": "999px",
        "rule": "1px solid",
        "code_radius": "18px",
        "accent_bar": "3px"
      },
      "shadow": {
        "sheet": "0 1px 1px rgba(0,0,0,.02),0 6px 26px rgba(0,0,0,.05)",
        "widget": "none",
        "card_hover": "0 10px 28px -16px rgba(28,27,23,0.35)"
      },
      "motion": {
        "hover": "160ms ease"
      }
    }
  },
  "page": "http://google-preview.miscsubjects.com/a/semaglutide-glp1-agonists",
  "json": "http://google-preview.miscsubjects.com/a/semaglutide-glp1-agonists.json",
  "markdown": "http://google-preview.miscsubjects.com/a/semaglutide-glp1-agonists.md",
  "theme": "http://google-preview.miscsubjects.com/article-theme.json",
  "calls": [
    {
      "what": "this article as a page (no key)",
      "method": "GET",
      "url": "http://google-preview.miscsubjects.com/a/semaglutide-glp1-agonists",
      "headers": {}
    },
    {
      "what": "this article as its object (no key)",
      "method": "GET",
      "url": "http://google-preview.miscsubjects.com/a/semaglutide-glp1-agonists.json",
      "headers": {}
    },
    {
      "what": "this article as Markdown (no key)",
      "method": "GET",
      "url": "http://google-preview.miscsubjects.com/a/semaglutide-glp1-agonists.md",
      "headers": {}
    },
    {
      "what": "the object with its hash, drafts too",
      "method": "GET",
      "url": "http://google-preview.miscsubjects.com/api/jarticles/semaglutide-glp1-agonists",
      "headers": {
        "x-sheets-key": "$(cat /Users/cyrusmassoumi/.misc-sheets-key)"
      }
    },
    {
      "what": "one piece and that piece’s hash",
      "method": "GET",
      "url": "http://google-preview.miscsubjects.com/api/jarticles/semaglutide-glp1-agonists/at?path=facts",
      "headers": {
        "x-sheets-key": "$(cat /Users/cyrusmassoumi/.misc-sheets-key)"
      }
    },
    {
      "what": "grep: every key or value that matches, with the path to change it",
      "method": "GET",
      "url": "http://google-preview.miscsubjects.com/api/jarticles/semaglutide-glp1-agonists/grep?q=owner",
      "headers": {
        "x-sheets-key": "$(cat /Users/cyrusmassoumi/.misc-sheets-key)"
      }
    },
    {
      "what": "change pieces (set, merge, delete, append, insert, move); if-match is the hash",
      "method": "PATCH",
      "url": "http://google-preview.miscsubjects.com/api/jarticles/semaglutide-glp1-agonists",
      "headers": {
        "x-sheets-key": "$(cat /Users/cyrusmassoumi/.misc-sheets-key)",
        "content-type": "application/json",
        "if-match": "<hash from the read>"
      },
      "body": {
        "ops": [
          {
            "op": "set",
            "path": "facts.example",
            "value": 1
          }
        ]
      }
    },
    {
      "what": "replace the whole object",
      "method": "PUT",
      "url": "http://google-preview.miscsubjects.com/api/jarticles/semaglutide-glp1-agonists",
      "headers": {
        "x-sheets-key": "$(cat /Users/cyrusmassoumi/.misc-sheets-key)",
        "content-type": "application/json",
        "if-match": "<hash>"
      },
      "body": {
        "slug": "semaglutide-glp1-agonists",
        "title": "…"
      }
    },
    {
      "what": "fetch every source, hash what came back and check the quote is in it",
      "method": "POST",
      "url": "http://google-preview.miscsubjects.com/api/jarticles/semaglutide-glp1-agonists/verify",
      "headers": {
        "x-sheets-key": "$(cat /Users/cyrusmassoumi/.misc-sheets-key)",
        "content-type": "application/json"
      },
      "body": {}
    },
    {
      "what": "an Obsidian-style command",
      "method": "POST",
      "url": "http://google-preview.miscsubjects.com/api/jarticles/cli",
      "headers": {
        "x-sheets-key": "$(cat /Users/cyrusmassoumi/.misc-sheets-key)",
        "content-type": "application/json"
      },
      "body": {
        "command": "backlinks",
        "file": "semaglutide-glp1-agonists"
      }
    }
  ]
}